COP: FY25 Deep Dive
FY25 revenue $58.9B (+8%), production 2,375 MBOED (+19% on full-year Marathon Oil contribution). Net income $7.99B (-13%) on lower realized prices. Capital return $9.0B = 46% of operating cash flow ($4.0B div + $5.0B buybacks). Dividend per share +26% to $3.18 — but VROC eliminated. Wells Fargo PT raise $133 → $183 the new Street high.
Key Takeaways
ConocoPhillips closed fiscal 2025 (calendar year ended December 31, 2025) at $58.9 billion of sales and other operating revenues, up 7.9% YoY — driven by full-year contribution from the Marathon Oil acquisition (closed November 2024). Average daily production stepped to 2,375 MBOED (vs 1,987 MBOED FY24, +19%) and annual production was 867 MMBOE (vs 727 MMBOE). Net income was $7.99 billion (vs $9.22B FY24, -13%) — the decline reflects lower realized oil prices in H2 (Brent averaged below FY24 levels) plus Marathon-integration costs. Operating income was $11.5 billion. Diluted EPS $6.35 (-19%). The Marathon Oil deal generated >$1 billion of run-rate synergies by year-end plus ~$1B of one-time tax benefits (foreign tax credits + NOLs). Capital return totaled $9.0 billion ($4.0B ordinary dividends + $5.0B buybacks) — representing 46% of operating cash flow. The structural change in capital allocation: VROC (variable return of cash) payments were eliminated in 2025 ($0 vs $0.60/share FY24, $2.50/share FY23) — the company has shifted to a higher ordinary dividend ($3.18/share FY25, +26% YoY, plus an 8% Q4 raise to $0.84/share) plus larger fixed buyback program. The Q4 2025 8% dividend raise to $0.84/share (annualized $3.36) is the new run-rate. Sell-side coverage is 11 analysts: 8 Buy / 3 Hold / 0 Sell, consensus PT $138.45, range $112-$183. Wells Fargo's April PT raise from $133 to $183 — a +$50 (+38%) step — is the most striking action in the window.
Main business structure
ConocoPhillips is a pure-play E&P (exploration and production) company — no downstream operations, no chemicals. Reporting is by geographic segment:
| Segment (geography) | Approx FY25 Production share | End-market |
|---|---|---|
| Lower 48 (US ex-Alaska) | ~62% | Permian + Eagle Ford + Bakken |
| Alaska | ~7% | North Slope (Prudhoe Bay, Kuparuk, Willow project) |
| Canada | ~5% | Surmont oil sands |
| Europe + Africa + Middle East | ~12% | Norway, UK, Libya, Qatar |
| Asia Pacific | ~14% | Australia, Indonesia, Malaysia, China |
Lower 48 (~62% of production) is the dominant geography — Permian (Wolfcamp / Bone Spring) + Eagle Ford + Bakken acreage, expanded by the Marathon acquisition which added Eagle Ford + Bakken + Permian acreage at scale. Marathon contributed ~400 MBOED to FY25 production on a full-year basis.
Alaska (~7%) is the long-cycle Arctic position. The Willow project (located in the National Petroleum Reserve, Alaska) is the major capital project — expected first oil ~2029, peak production ~180 Mbbl/day, ~$8B project cost.
Canada (~5%) is the Surmont oil sands position (steam-assisted gravity drainage / SAGD) — long-life production with stable cash generation.
International (~26%) is Norway (Greater Ekofisk), UK (Britannia, J-Block), Libya, Qatar (LNG project), Australia (Bayu-Undan / Barossa), Indonesia (Corridor / Natuna), Malaysia.
Marathon Oil integration (closed November 2024). Full asset integration completed H1 2025; year-end FY25 achieved >$1B run-rate synergies (vs $500M initial guide) plus $1B of one-time tax benefits. The deal was 100% stock-for-stock — adding shares (which is why buyback pace held flat $5.5B → $5.0B even on accelerated returns).
Customer concentration. Direct sales to refining + trading customers globally; no 10%+ customer concentration disclosed.
Scale anchors. ~10,000 employees. Reserves: ~6 billion BOE proved. Production 2,375 MBOED — making COP the largest US-listed pure-play E&P (vs Pioneer pre-XOM acquisition, Devon, EOG).
Key core metrics (3-year trend)
1. Production growth — Marathon-driven step-up
| FY23 | FY24 | FY25 | |
|---|---|---|---|
| Total production (MBOED) | 1,826 | 1,987 | 2,375 |
| YoY | — | +9% | +19% |
| Annual production (MMBOE) | 666 | 727 | 867 |
The +19% FY25 production step is largely Marathon (acquisition closed Nov 2024) plus continued Permian organic growth. FY26 will be the first full apples-to-apples post-deal year — Street modeling 2.45-2.55 MMBOED.
2. Earnings — distorted by oil prices and integration
| FY23 | FY24 | FY25 | |
|---|---|---|---|
| Revenue ($B) | 56.1 | 54.6 | 58.9 |
| Net income ($B) | 11.0 | 9.2 | 8.0 |
| Diluted EPS | $9.06 | $7.81 | $6.35 |
Net income compressed despite production growth — lower realized oil prices in H2 + integration costs. The leverage to Brent / WTI is structural in pure-play E&P.
3. Capital allocation evolution — fixed dividend + buyback, no VROC
| FY23 | FY24 | FY25 | |
|---|---|---|---|
| Ordinary div per share | $2.11 | $2.52 | $3.18 |
| VROC per share | $2.50 | $0.60 | $0 |
| Total div per share | $4.61 | $3.12 | $3.18 |
| Buybacks ($B) | 5.4 | 5.5 | 5.0 |
| Total return ($B) | — | — | $9.0 |
| Capital return / OCF | — | — | 46% |
The structural shift: VROC eliminated in FY25 ($0 from $2.50 in FY23). The new model is fixed ordinary dividend (raised 8% in Q4 2025 to $0.84/share quarterly = $3.36/year run-rate going into FY26) + sustained buyback program (~$5B/year). The capital return at 46% of OCF is moderate vs peer integrated majors (CVX 73%, XOM 65-70%) — reflecting capital reinvestment in Permian + Willow + Marathon integration.
4. Cumulative buyback authorization
Cumulative buybacks since program inception (2016) through Dec 31 2025: 486.1 million shares for $39.3 billion. Board authorization $65 billion aggregate — $25.7B remaining.
Market evaluation
Sell-side coverage (as of April 27, 2026). 11 analysts cover the stock.
| Rating | Count |
|---|---|
| Buy / Outperform / Overweight | 8 |
| Hold / Neutral | 3 |
| Sell | 0 |
Price targets. Consensus $138.45, range $112 (low: Roth Capital, Neutral) to $183 (high: Wells Fargo, OW).
Recent analyst activity (February through April 2026). 16 covered actions in the window — mostly PT raises with one downgrade and one new initiation:
- Wells Fargo (Sam Margolin): $133 → $183 on April 9 — the largest single PT raise (+$50), OW maintained, Street-high
- Truist Securities (Gabe Daoud): initiated Hold at $124 on March 24
- Roth Capital (Leo Mariani): downgraded Buy → Neutral on February 17 — the lone downgrade in window, PT held at $112 (Street-low)
- Other firms maintained ratings with PT raises in $5-25 range
The Wells Fargo +$50 raise stands out — it appears to reflect a thesis-revisit on Marathon synergy capture + Permian acreage value. The Roth downgrade was on macro / cycle risk concerns. The Truist Hold initiation took the cautious path post-Marathon-integration.
Buy-side positioning. COP is a core E&P holding paired with EOG / Devon / OXY in pure-play E&P baskets. Trades at a multiple discount to integrated majors on E&P-only profile but premium to pure-play peers on portfolio diversification (Alaska + International). Short interest below 1.5% of float.
FY25 corporate structure: Marathon-integration year, capital allocation reset
FY25 is the year that the Marathon Oil integration thesis printed (>$1B run-rate synergies achieved by year-end vs $500M initial guide) and the capital allocation framework reset structurally — VROC eliminated, ordinary dividend stepped up 26% to $3.18/share, and a Q4 8% raise to $3.36 annualized established the FY26 run-rate. Production grew +19% to 2.38 MMBOED on Marathon contribution. The bull case for the +$50 Wells Fargo PT raise to $183: synergy upside continues into FY26-FY27, Permian compounding, Willow project FY29 first oil providing long-cycle production growth, and the simplified capital return framework (fixed div + buyback) more attractive to dividend-yield investors than the VROC volatility. The bear case for the Roth downgrade and Hold camp: oil price cycle exposure, integration execution residual risk, and the $5.0B/year buyback pace requiring elevated FCF generation. The Q1 FY26 earnings print this week is the proximate event for measuring early FY26 production trajectory and any updated synergy / Willow capex commentary.